FDA approves Wegovy pill for weight loss
Digest more
The Danish drugmaker will start selling a pill version of its Wegovy weight-loss medicine in January, after [securing ...
As Novo Nordisk’s weight-loss pill Wegovy (semaglutide) readies for a launch in the United States early January, it will be a ...
Novo Nordisk's FDA-approved weight-loss pill intensifies its rivalry with Eli Lilly, putting health care and biotech ETFs in ...
Novo Nordisk rises as FDA approves Wegovy pill for obesity. Mercedes to pay $150M settlement over diesel scandal. ByteDance ...
Novo Nordisk A/S (NYSE: NVO) is one of the Best Non-US Stocks to Buy According to Hedge Funds. On December 12, Novo Nordisk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback